Clinical Trials Logo

Cardiac Arrhythmia clinical trials

View clinical trials related to Cardiac Arrhythmia.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06351956 Not yet recruiting - Cardiac Arrhythmia Clinical Trials

New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes.

Start date: April 20, 2024
Phase:
Study type: Observational

New Onset Cardiac Arrhythmias in Septic Patients in Critical Care Setting, Predictors and Outcomes

NCT ID: NCT06164808 Not yet recruiting - Cardiac Arrhythmia Clinical Trials

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

CATCH
Start date: December 15, 2023
Phase: N/A
Study type: Interventional

Heart rhythm disorders are common and significantly impact the lives of those affected and their families. The main problems can be categorized as: a) atrial fibrillation or AF and atrial flutter, b) supra-ventricular tachycardia or SVT, c) excessively slow heart beats (i.e., bradycardia or pauses) and d) ventricular arrhythmias. These problems can be difficult to detect with currently available monitoring options as they are all worn for shorter terms or are an invasive implantable option. The HeartWatch is a longer term monitoring system that is worn on the upper arm, allows users to create a tag and pairs with an app on a smartphone allowing for correlation of symptoms.

NCT ID: NCT06096246 Not yet recruiting - Clinical trials for Persistent Atrial Fibrillation

Investigation of Cardioversion Versus Therapeutic Ablation for Persistent AF (ORBICA-AF)

ORBICA-AF
Start date: August 5, 2024
Phase: N/A
Study type: Interventional

The main aim of the research is to investigate whether patients undergoing pulmonary vein isolation with catheter ablation for persistent atrial fibrillation (AF) will have lower rates of AF recurrence than those treated by DC cardioversion without an ablation procedure.

NCT ID: NCT06082388 Not yet recruiting - Cardiac Arrhythmia Clinical Trials

Atropine vs Isoprenaline in the Invasive Diagnosis of Arrhythmias

Start date: November 9, 2023
Phase: N/A
Study type: Interventional

During electrophysiological study (EPS) multiple drugs are used to reveal arrhythmias and/or conductive system disorders. Two most often used agents are atropine and isoprenaline. Due to their distinct pharmacological properties, they are affecting myocardium in different manner. Those dissimilarities can affect the EPS course and long-term prognosis. The aim of presented study is to evaluate the optimal protocol of pharmacotherapy during EPS.

NCT ID: NCT05401656 Not yet recruiting - Neoplasms Clinical Trials

A Study to Validate the Apple Watch's ECG Application in Children During or After Cancer Therapy

Start date: May 30, 2022
Phase: N/A
Study type: Interventional

A prospective study in paediatric, adolescent and young adult patients aged 7 to 18 years to validate the use of the Apple Watch's electrocardiogram (ECG) function in measuring QT prolongation during and or after cancer therapy.

NCT ID: NCT05217485 Not yet recruiting - Atrial Fibrillation Clinical Trials

Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis

CAMS-AF
Start date: March 2022
Phase: N/A
Study type: Interventional

To detect atrial fibrillation after infection.

NCT ID: NCT04295291 Not yet recruiting - Cardiac Arrest Clinical Trials

Quality of Cardiopulmonary Resuscitation Pre- and Intra Hospital

Start date: January 1, 2025
Phase:
Study type: Observational [Patient Registry]

The survival after intrahospital cardiac arrest has been reported to 15%. In Norway this varies between 16 and 23%.). Many factors are associated with survival after cardiac arrest, both intra- and prehospital. Recent studies have not included information about individual patient factors and the outcome after cardiopulmonary resuscitation (CPR). In the current hospital, we are able to record patient specific information related to a cardiac arrest/CPR situation, and thereby be able to assess patient-related factors associated with both detection, treatment and outcome of CPR.

NCT ID: NCT02665442 Not yet recruiting - Atrial Fibrillation Clinical Trials

Retracting the Esophagus During AF Ablation

EsoSure
Start date: January 2016
Phase: N/A
Study type: Interventional

This Study is designed to determine the outcome and effect of implementation of Esophageal Stylet as a strategy to minimize the risk of esophageal injury during the atrial fibrillation catheter ablation procedure.